.Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B02B_VitaminKAndOtherHemostatics.B02BD11_Catridecacog.Catridecacog .Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B02B_VitaminKAndOtherHemostatics.B02BD11_Catridecacog.Catridecacog| name: | Catridecacog |
| ATC code: | B02BD11 | route: | intravenous |
| n-compartments | 2 |
Catridecacog is a recombinant human coagulation factor XIII A-subunit used in the treatment and prophylaxis of bleeding in patients with congenital factor XIII A-subunit deficiency. It is approved for medical use in several countries and is administered to prevent or treat bleeding events associated with FXIII deficiency.
Reported in adult patients with congenital factor XIII A-subunit deficiency after intravenous administration of 35 IU/kg single dose.